Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$45,175,103
-$14,287,468 QoQ
Shares Held
7,788,811
+2.8% QoQ
Ownership
4.51%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 99.60106876389733.ToString("F0")%
Shared 0.ToString("F0")%
None 0.3989312361026606.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. XERS ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in XERS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,175,103 | 7,788,811 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $59,462,571 | 7,574,850 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $47,536,672 | 5,839,886 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,911,350 | 3,835,407 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,757,522 | 3,052,372 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,622,101 | 1,363,452 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,807,292 | 985,015 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,165,553 | 518,024 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,562,493 | 707,011 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,478,333 | 1,054,610 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,628,261 | 875,410 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,902,253 | 726,051 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $215,451 | 132,179 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $215,964 | 162,379 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $245,317 | 157,255 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $75,249 | 48,863 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $381,557 | 149,046 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||